1.Lehmann F, Alary PE, Rey G, Slama R. Association of daily temperature with suicide mortality: a comparison with other causes of death and characterization of possible attenuation across 5 decades. American journal of epidemiology. 2022;
1.Fouillet A, Ghosn W, Naouri D, Coudin E. Covid-19 : troisième cause de décès en France en 2020, quand les autres grandes causes de décès baissent. Etudes et résultats. 2022;(1250):1–7.
1.Fouillet A, Ghosn W, Naouri D, Coudin E. Covid-19 : troisième cause de décès en France en 2020, quand les autres grandes causes baissent. Bull Epidémiol Hebd. 2022;Cov_16:2–15.
1.Lévy L, Robine JM, Rey G, Méndez Turrubiates RF, Quijal-Zamorano M, Achebak H, et al. Daylight saving time affects European mortality patterns. Nat Commun. 2022 Nov 14;13(1):6906.
1.Khlat M, Ghosn W, Guillot M, Vandentorren S, DcCOVMIG Research Team. Impact of the COVID-19 crisis on the mortality profiles of the foreign-born in France during the first pandemic wave. Soc Sci Med. 2022 Nov;313:115160.
1.Falissard L, Morgand C, Ghosn W, Imbaud C, Bounebache K, Rey G. Neural Translation and Automated Recognition of ICD-10 Medical Entities From Natural Language: Model Development and Performance Assessment. JMIR medical informatics. 2022;10(4):e26353.
1.Trinh NT, de Visme S, Cohen JF, Bruckner T, Lelong N, Adnot P, et al. Recent historic increase of infant mortality in France: A time-series analysis, 2001 to 2019. The Lancet Regional Health-Europe. 2022;16:100339.
1.Donzeau A, Piffaretti C, Jossens A, Levaillant L, Bouhours-Nouet N, Amsellem-Jager J, et al. Time trend in excess mortality in children with type 1 diabetes from 1987 to 2016 in mainland France. Pediatric diabetes. 2022;23(1):38–44.
Donzeau A, Piffaretti C, Jossens A, Levaillant L, Bouhours-Nouet N, Amsellem-Jager J, et al. TIME TREND IN EXCESS MORTALITY IN CHILDREN WITH TYPE 1 DIABETES FROM 1987 TO 2016 IN MAINLAND FRANCE. Pediatr Diabetes. 2021 Dec 8;
1.Jougla E, Papoz L, Balkau B, Maguin P, Hatton F. Death certificate coding practices related to diabetes in European countries--the “EURODIAB Subarea C” Study. Int J Epidemiol [Internet]. 1992 Apr [cited 2012 Jun 27];21(2):343–5Available from: http://www.ncbi.nlm.nih.gov/pubmed/1428491
1.Jougla E, Hatton F, Le Toullec A, Michel E. [Trends in mortality characteristics in Aids in France 1983-1990]. Rev Epidemiol Sante Publique [Internet]. 1992 [cited 2012 Jun 27];40(3):164–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1439058
1.Mackenbach JP, Bouvier-Colle MH, Jougla E. “Avoidable” mortality and health services: a review of aggregate data studies. J Epidemiol Community Health [Internet]. 1990 Jun [cited 2012 Jun 27];44(2):106–1Available from: http://www.ncbi.nlm.nih.gov/pubmed/2196328
1.Balkau B, Jougla E, Papoz L. European study of the certification and coding of causes of death of six clinical case histories of diabetic patients. EURODIAB Subarea C Study Group. Int J Epidemiol [Internet]. 1993 Feb [cited 2012 Jun 27];22(1):116–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8449631
1.Hatton F, Facy F, Jougla E. [Mortality and morbidity of drug addiction increases in France]. Rev Epidemiol Sante Publique [Internet]. 1993 [cited 2012 Jun 27];41(5):422–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8284483
1.Aïach P. Les inégalités sociales de santé en France et en Grande-Bretagne: analyse et étude comparative. Documentation française; 1987.
1.Jougla E, Ducimetière P, Bouvier-Colle MH, Hatton F. [Relation between the level of the development of the care system and the level of “preventable” mortality according to department in France]. Rev Epidemiol Sante Publique [Internet]. 1987 [cited 2012 Jun 27];35(5):365–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3432706